Meister Keith A. 4
Research Summary
AI-generated summary
GeneDx (WGS) 10% Owner Keith Meister Exercises Derivatives, Gets RSUs
What Happened Keith A. Meister, reported as a 10% owner of GeneDx Holdings Corp. (WGS), exercised/converted 3,576 derivative units on 2026-06-18 (acquired) and a matching 3,576 derivative units were reported as disposed the same day; he was also granted 4,248 restricted stock units (RSUs) on that date. All transactions show $0.00 per share (no cash consideration reported). The RSUs represent contingent rights to receive Class A common stock upon settlement.
Key Details
- Transaction date: 2026-06-18; Form 4 filed 2026-06-23.
- Exercises/conversions: 3,576 derivative units acquired (M code) and 3,576 derivative units disposed (M code) — price $0.00.
- Grant/award: 4,248 RSUs (A code) — price $0.00; RSUs are contingent rights to receive 1 share each upon settlement (see footnote F1).
- Shares owned after the transaction: not disclosed in the provided filing excerpt.
- Notable footnotes:
- F1: Each RSU equals a contingent right to 1 share upon settlement for no consideration.
- F4/F5: Vesting schedules noted — some awards vest on the earlier of the 2026 or 2027 annual meeting or first anniversary of grant, subject to continued service.
- F2/F3: Reporting Person may have indirect beneficial ownership via investment funds advised by Corvex Management LP and CMLS Holdings LLC.
- Reporting person disclaims beneficial ownership except to the extent of any pecuniary interest.
Context
- These filings show derivative conversion/exercise activity plus an RSU grant; the matching acquisition and disposal of 3,576 derivative units suggests the exercised units were not retained, but the filing does not disclose sale proceeds or further details.
- As a reported 10% owner with indirect holdings via investment vehicles, Meister’s activity can reflect institutional or governance-related actions rather than routine employee buys/sells.
- No 10b5‑1 plan or tax‑withholding details were disclosed in the provided excerpt.